NATERA, INC. Capital Expenditures Incurred but Not yet Paid
NATERA, INC. (NTRA) reported Capital Expenditures Incurred but Not yet Paid of $4.22 million for the 3-month period ending 2025-03-31, per its 10-Q filed 2025-05-09.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:CapitalExpendituresIncurredButNotYetPaid · last filed 2025-05-09
- NATERA, INC. capital expenditures incurred but not yet paid for the quarter ending 2025-03-31 was $4.22M, a 3670.54% increase year-over-year.
- NATERA, INC. capital expenditures incurred but not yet paid for the quarter ending 2024-03-31 was $112.00K, a 93.06% decline year-over-year.
- NATERA, INC. capital expenditures incurred but not yet paid for the quarter ending 2023-06-30 was -$1.51M.
- NATERA, INC. capital expenditures incurred but not yet paid for the quarter ending 2023-03-31 was $1.61M, a 23.04% decline year-over-year.
- NATERA, INC. capital expenditures incurred but not yet paid for fiscal 2021 was $5.17M, a 86.01% increase from fiscal 2020.
- NATERA, INC. capital expenditures incurred but not yet paid for fiscal 2020 was $2.78M, a 24.96% decline from fiscal 2019.
- NATERA, INC. capital expenditures incurred but not yet paid for fiscal 2019 was $3.71M, a 1282.84% increase from fiscal 2018.
- NATERA, INC. capital expenditures incurred but not yet paid for fiscal 2018 was $268.00K, a 40.04% decline from fiscal 2017.
| Period end | Capital Expenditures Incurred but Not yet Paid 3 month | Capital Expenditures Incurred but Not yet Paid 6 month | Capital Expenditures Incurred but Not yet Paid 9 month | Capital Expenditures Incurred but Not yet Paid 12 month |
|---|---|---|---|---|
| 2025-03-31 | $4.22M 10-Q · filed 2025-05-09 | |||
| 2024-03-31 | $112.00K 10-Q · filed 2025-05-09 | |||
| 2023-06-30 | -$1.51M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-04 | $103.00K 10-Q · filed 2023-08-04 | ||
| 2023-03-31 | $1.61M 10-Q · filed 2024-05-10 | |||
| 2022-09-30 | -$1.58M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | -$1.64M derived: sum of 2 quarters · filed 2023-08-04 | $458.00K 10-Q · filed 2022-11-09 | $674.00K derived: sum of 4 quarters · filed 2023-08-04 |
| 2022-06-30 | -$61.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-04 | $2.04M 10-Q · filed 2023-08-04 | $2.25M derived: sum of 3 quarters · filed 2023-08-04 | $2.52M derived: sum of 4 quarters · filed 2023-08-04 |
| 2022-03-31 | $2.10M 10-Q · filed 2023-05-10 | $2.31M derived: sum of 2 quarters · filed 2023-05-10 | $2.58M derived: sum of 3 quarters · filed 2023-05-10 | $5.37M derived: sum of 4 quarters · filed 2023-05-10 |
| 2021-12-31 | $216.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-25 | $485.00K derived: sum of 2 quarters · filed 2022-11-09 | $3.27M derived: sum of 3 quarters · filed 2022-11-09 | $5.17M 10-K · filed 2022-02-25 |
| 2021-09-30 | $269.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $3.06M derived: sum of 2 quarters · filed 2022-11-09 | $4.96M 10-Q · filed 2022-11-09 | $4.92M derived: sum of 4 quarters · filed 2022-11-09 |
| 2021-06-30 | $2.79M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-05 | $4.69M 10-Q · filed 2022-08-05 | $4.66M derived: sum of 3 quarters · filed 2022-08-05 | $7.21M derived: sum of 4 quarters · filed 2022-08-05 |
| 2021-03-31 | $1.90M 10-Q · filed 2022-05-06 | $1.86M derived: sum of 2 quarters · filed 2022-05-06 | $4.42M derived: sum of 3 quarters · filed 2022-05-06 | $2.02M derived: sum of 4 quarters · filed 2022-05-06 |
| 2020-12-31 | -$33.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-25 | $2.53M derived: sum of 2 quarters · filed 2022-02-25 | $124.00K derived: sum of 3 quarters · filed 2022-02-25 | $2.78M 10-K · filed 2022-02-25 |
| 2020-09-30 | $2.56M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-05 | $157.00K derived: sum of 2 quarters · filed 2021-11-05 | $2.81M 10-Q · filed 2021-11-05 | $6.46M derived: sum of 4 quarters · filed 2022-02-25 |
| 2020-06-30 | -$2.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-06 | $255.00K 10-Q · filed 2021-08-06 | $3.90M derived: sum of 3 quarters · filed 2022-02-25 | $3.96M derived: sum of 4 quarters · filed 2022-02-25 |
| 2020-03-31 | $2.66M 10-Q · filed 2021-05-07 | $6.31M derived: sum of 2 quarters · filed 2022-02-25 | $6.36M derived: sum of 3 quarters · filed 2022-02-25 | $6.69M derived: sum of 4 quarters · filed 2022-02-25 |
| 2019-12-31 | $3.65M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-25 | $3.71M derived: sum of 2 quarters · filed 2022-02-25 | $4.03M derived: sum of 3 quarters · filed 2022-02-25 | $3.71M 10-K · filed 2022-02-25 |
| 2019-09-30 | $56.00K 10-Q · filed 2020-11-06 | $379.00K derived: sum of 2 quarters · filed 2020-11-06 | $56.00K 10-Q · filed 2019-11-08 | |
| 2019-06-30 | $323.00K 10-Q · filed 2020-08-07 | $323.00K 10-Q · filed 2019-08-09 | ||
| 2019-03-31 | $199.00K 10-Q · filed 2020-05-08 | |||
| 2018-12-31 | $268.00K 10-K · filed 2021-02-26 | |||
| 2018-03-31 | $209.00K 10-Q · filed 2019-05-10 | |||
| 2017-12-31 | $447.00K 10-K · filed 2020-03-02 | |||
| 2016-12-31 | $5.20M 10-K · filed 2019-03-15 | |||
| 2015-12-31 | -$361.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15 | $138.00K derived: sum of 2 quarters · filed 2018-03-15 | $765.00K 10-K · filed 2018-03-15 | |
| 2015-09-30 | $499.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-13 | $1.13M 10-Q · filed 2015-11-13 | ||
| 2015-06-30 | $627.00K 10-Q · filed 2015-08-13 | |||
| 2014-12-31 | $2.29M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | $2.54M derived: sum of 2 quarters · filed 2017-03-16 | $3.22M 10-K · filed 2017-03-16 | |
| 2014-09-30 | $260.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-13 | $938.00K 10-Q · filed 2015-11-13 | ||
| 2014-06-30 | $678.00K 10-Q · filed 2015-08-13 | |||
| 2013-12-31 | $2.94M 10-K · filed 2016-03-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| QUEST DIAGNOSTICS INC (DGX) | United States | $26.096B | 22.09 |
| LABCORP HOLDINGS INC. (LH) | United States | $25.060B | 22.60 |
| Guardant Health, Inc. (GH) | United States | $23.675B | -12.65 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |